nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—NPPB—nervous system—Gilles de la Tourette syndrome	0.0225	0.0472	CbGeAlD
Carvedilol—NPPB—central nervous system—Gilles de la Tourette syndrome	0.0217	0.0454	CbGeAlD
Carvedilol—SELE—midbrain—Gilles de la Tourette syndrome	0.0185	0.0388	CbGeAlD
Carvedilol—NPPB—brain—Gilles de la Tourette syndrome	0.0172	0.0361	CbGeAlD
Carvedilol—VCAM1—midbrain—Gilles de la Tourette syndrome	0.017	0.0357	CbGeAlD
Carvedilol—HIF1A—midbrain—Gilles de la Tourette syndrome	0.0164	0.0343	CbGeAlD
Carvedilol—GJA1—midbrain—Gilles de la Tourette syndrome	0.0159	0.0333	CbGeAlD
Carvedilol—Tamsulosin—DRD3—Gilles de la Tourette syndrome	0.0157	0.591	CrCbGaD
Carvedilol—SELE—nervous system—Gilles de la Tourette syndrome	0.0152	0.0319	CbGeAlD
Carvedilol—SELE—central nervous system—Gilles de la Tourette syndrome	0.0147	0.0307	CbGeAlD
Carvedilol—VCAM1—nervous system—Gilles de la Tourette syndrome	0.014	0.0293	CbGeAlD
Carvedilol—NDUFC2—midbrain—Gilles de la Tourette syndrome	0.0138	0.029	CbGeAlD
Carvedilol—VCAM1—central nervous system—Gilles de la Tourette syndrome	0.0135	0.0282	CbGeAlD
Carvedilol—HIF1A—nervous system—Gilles de la Tourette syndrome	0.0135	0.0282	CbGeAlD
Carvedilol—GJA1—nervous system—Gilles de la Tourette syndrome	0.0131	0.0274	CbGeAlD
Carvedilol—HIF1A—central nervous system—Gilles de la Tourette syndrome	0.013	0.0272	CbGeAlD
Carvedilol—GJA1—central nervous system—Gilles de la Tourette syndrome	0.0126	0.0264	CbGeAlD
Carvedilol—SELE—brain—Gilles de la Tourette syndrome	0.0116	0.0244	CbGeAlD
Carvedilol—NDUFC2—nervous system—Gilles de la Tourette syndrome	0.0114	0.0238	CbGeAlD
Carvedilol—NDUFC2—central nervous system—Gilles de la Tourette syndrome	0.011	0.0229	CbGeAlD
Carvedilol—Tamsulosin—DRD2—Gilles de la Tourette syndrome	0.0109	0.409	CrCbGaD
Carvedilol—VCAM1—brain—Gilles de la Tourette syndrome	0.0107	0.0224	CbGeAlD
Carvedilol—HIF1A—brain—Gilles de la Tourette syndrome	0.0103	0.0216	CbGeAlD
Carvedilol—GJA1—brain—Gilles de la Tourette syndrome	0.01	0.0209	CbGeAlD
Carvedilol—NDUFC2—brain—Gilles de la Tourette syndrome	0.0087	0.0182	CbGeAlD
Carvedilol—VEGFA—brain—Gilles de la Tourette syndrome	0.00789	0.0165	CbGeAlD
Carvedilol—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.0069	0.0144	CbGeAlD
Carvedilol—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.00675	0.0141	CbGeAlD
Carvedilol—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.00664	0.0139	CbGeAlD
Carvedilol—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.00649	0.0136	CbGeAlD
Carvedilol—ADRA1B—brain—Gilles de la Tourette syndrome	0.00527	0.011	CbGeAlD
Carvedilol—ADRA1D—brain—Gilles de la Tourette syndrome	0.00516	0.0108	CbGeAlD
Carvedilol—ADRB1—nervous system—Gilles de la Tourette syndrome	0.0049	0.0103	CbGeAlD
Carvedilol—ADRB1—central nervous system—Gilles de la Tourette syndrome	0.00472	0.00988	CbGeAlD
Carvedilol—KCNH2—midbrain—Gilles de la Tourette syndrome	0.00455	0.00953	CbGeAlD
Carvedilol—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.00449	0.0094	CbGeAlD
Carvedilol—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.00387	0.00811	CbGeAlD
Carvedilol—ADRB1—brain—Gilles de la Tourette syndrome	0.00375	0.00784	CbGeAlD
Carvedilol—KCNH2—nervous system—Gilles de la Tourette syndrome	0.00374	0.00783	CbGeAlD
Carvedilol—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.00373	0.00781	CbGeAlD
Carvedilol—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.00369	0.00773	CbGeAlD
Carvedilol—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.0036	0.00754	CbGeAlD
Carvedilol—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.00358	0.0075	CbGeAlD
Carvedilol—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.00355	0.00744	CbGeAlD
Carvedilol—CYP1A1—nervous system—Gilles de la Tourette syndrome	0.00316	0.00662	CbGeAlD
Carvedilol—CYP1A1—central nervous system—Gilles de la Tourette syndrome	0.00304	0.00637	CbGeAlD
Carvedilol—ADRA1A—brain—Gilles de la Tourette syndrome	0.00296	0.0062	CbGeAlD
Carvedilol—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.00295	0.00617	CbGeAlD
Carvedilol—CYP2E1—nervous system—Gilles de la Tourette syndrome	0.00288	0.00603	CbGeAlD
Carvedilol—KCNH2—brain—Gilles de la Tourette syndrome	0.00286	0.00599	CbGeAlD
Carvedilol—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.00284	0.00594	CbGeAlD
Carvedilol—ADRA2C—brain—Gilles de la Tourette syndrome	0.00282	0.00591	CbGeAlD
Carvedilol—PTGS1—nervous system—Gilles de la Tourette syndrome	0.00278	0.00581	CbGeAlD
Carvedilol—CYP2E1—central nervous system—Gilles de la Tourette syndrome	0.00277	0.00581	CbGeAlD
Carvedilol—PTGS1—central nervous system—Gilles de la Tourette syndrome	0.00267	0.0056	CbGeAlD
Carvedilol—CYP1A1—brain—Gilles de la Tourette syndrome	0.00242	0.00506	CbGeAlD
Carvedilol—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00232	0.00485	CbGeAlD
Carvedilol—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.00228	0.00478	CbGeAlD
Carvedilol—ADRA2A—brain—Gilles de la Tourette syndrome	0.00225	0.00471	CbGeAlD
Carvedilol—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00223	0.00467	CbGeAlD
Carvedilol—CYP2E1—brain—Gilles de la Tourette syndrome	0.0022	0.00461	CbGeAlD
Carvedilol—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.0022	0.0046	CbGeAlD
Carvedilol—PTGS1—brain—Gilles de la Tourette syndrome	0.00212	0.00444	CbGeAlD
Carvedilol—ABCB1—midbrain—Gilles de la Tourette syndrome	0.002	0.00418	CbGeAlD
Carvedilol—CYP2D6—brain—Gilles de la Tourette syndrome	0.00174	0.00365	CbGeAlD
Carvedilol—ABCB1—nervous system—Gilles de la Tourette syndrome	0.00164	0.00344	CbGeAlD
Carvedilol—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.00158	0.00331	CbGeAlD
Carvedilol—ABCB1—brain—Gilles de la Tourette syndrome	0.00125	0.00263	CbGeAlD
Carvedilol—KCNH2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.0012	0.00242	CbGpPWpGaD
Carvedilol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00119	0.00239	CbGpPWpGaD
Carvedilol—XDH—Metabolism—HDC—Gilles de la Tourette syndrome	0.00112	0.00226	CbGpPWpGaD
Carvedilol—VEGFA—Focal Adhesion—MET—Gilles de la Tourette syndrome	0.0011	0.00222	CbGpPWpGaD
Carvedilol—ADRB3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000999	0.00202	CbGpPWpGaD
Carvedilol—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000998	0.00201	CbGpPWpGaD
Carvedilol—ADRA2B—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000971	0.00196	CbGpPWpGaD
Carvedilol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00097	0.00196	CbGpPWpGaD
Carvedilol—ADRB3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00097	0.00196	CbGpPWpGaD
Carvedilol—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000969	0.00195	CbGpPWpGaD
Carvedilol—ADRA2B—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000942	0.0019	CbGpPWpGaD
Carvedilol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000909	0.00183	CbGpPWpGaD
Carvedilol—ADRA2C—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000907	0.00183	CbGpPWpGaD
Carvedilol—ADRB3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000904	0.00182	CbGpPWpGaD
Carvedilol—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000902	0.00182	CbGpPWpGaD
Carvedilol—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000901	0.00182	CbGpPWpGaD
Carvedilol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000889	0.00179	CbGpPWpGaD
Carvedilol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000883	0.00178	CbGpPWpGaD
Carvedilol—ADRA2C—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00088	0.00178	CbGpPWpGaD
Carvedilol—ADRA2B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000878	0.00177	CbGpPWpGaD
Carvedilol—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000875	0.00176	CbGpPWpGaD
Carvedilol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000863	0.00174	CbGpPWpGaD
Carvedilol—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000855	0.00172	CbGpPWpGaD
Carvedilol—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000841	0.0017	CbGpPWpGaD
Carvedilol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000831	0.00168	CbGpPWpGaD
Carvedilol—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00083	0.00167	CbGpPWpGaD
Carvedilol—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000828	0.00167	CbGpPWpGaD
Carvedilol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000822	0.00166	CbGpPWpGaD
Carvedilol—ADRA2C—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00082	0.00165	CbGpPWpGaD
Carvedilol—ADRA1D—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000818	0.00165	CbGpPWpGaD
Carvedilol—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000817	0.00165	CbGpPWpGaD
Carvedilol—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000815	0.00164	CbGpPWpGaD
Carvedilol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000804	0.00162	CbGpPWpGaD
Carvedilol—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000804	0.00162	CbGpPWpGaD
Carvedilol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000779	0.00157	CbGpPWpGaD
Carvedilol—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000773	0.00156	CbGpPWpGaD
Carvedilol—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000772	0.00156	CbGpPWpGaD
Carvedilol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000762	0.00154	CbGpPWpGaD
Carvedilol—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000761	0.00154	CbGpPWpGaD
Carvedilol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000756	0.00153	CbGpPWpGaD
Carvedilol—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000749	0.00151	CbGpPWpGaD
Carvedilol—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000749	0.00151	CbGpPWpGaD
Carvedilol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00074	0.00149	CbGpPWpGaD
Carvedilol—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000737	0.00149	CbGpPWpGaD
Carvedilol—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000736	0.00148	CbGpPWpGaD
Carvedilol—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000731	0.00148	CbGpPWpGaD
Carvedilol—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000721	0.00145	CbGpPWpGaD
Carvedilol—VEGFA—Axon guidance—MET—Gilles de la Tourette syndrome	0.000719	0.00145	CbGpPWpGaD
Carvedilol—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000715	0.00144	CbGpPWpGaD
Carvedilol—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000714	0.00144	CbGpPWpGaD
Carvedilol—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00071	0.00143	CbGpPWpGaD
Carvedilol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000704	0.00142	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000701	0.00141	CbGpPWpGaD
Carvedilol—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0007	0.00141	CbGpPWpGaD
Carvedilol—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000698	0.00141	CbGpPWpGaD
Carvedilol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000689	0.00139	CbGpPWpGaD
Carvedilol—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000689	0.00139	CbGpPWpGaD
Carvedilol—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000684	0.00138	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00068	0.00137	CbGpPWpGaD
Carvedilol—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000679	0.00137	CbGpPWpGaD
Carvedilol—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000666	0.00134	CbGpPWpGaD
Carvedilol—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000665	0.00134	CbGpPWpGaD
Carvedilol—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000664	0.00134	CbGpPWpGaD
Carvedilol—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000652	0.00132	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000651	0.00131	CbGpPWpGaD
Carvedilol—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000642	0.00129	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000634	0.00128	CbGpPWpGaD
Carvedilol—ADRB3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000633	0.00128	CbGpPWpGaD
Carvedilol—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000632	0.00128	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000632	0.00128	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00063	0.00127	CbGpPWpGaD
Carvedilol—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000618	0.00125	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000612	0.00123	CbGpPWpGaD
Carvedilol—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000607	0.00122	CbGpPWpGaD
Carvedilol—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000603	0.00122	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000593	0.0012	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000589	0.00119	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000588	0.00119	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000586	0.00118	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00058	0.00117	CbGpPWpGaD
Carvedilol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000576	0.00116	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000576	0.00116	CbGpPWpGaD
Carvedilol—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000571	0.00115	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000571	0.00115	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00057	0.00115	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000568	0.00115	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000565	0.00114	CbGpPWpGaD
Carvedilol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000563	0.00114	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000563	0.00114	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000549	0.00111	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000548	0.00111	CbGpPWpGaD
Carvedilol—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000541	0.00109	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00054	0.00109	CbGpPWpGaD
Carvedilol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000539	0.00109	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000536	0.00108	CbGpPWpGaD
Carvedilol—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000533	0.00108	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000533	0.00108	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000532	0.00107	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00053	0.00107	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	0.000526	0.00106	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000525	0.00106	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000525	0.00106	CbGpPWpGaD
Carvedilol—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000525	0.00106	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000525	0.00106	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000513	0.00104	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000513	0.00103	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000511	0.00103	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000498	0.001	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000497	0.001	CbGpPWpGaD
Carvedilol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000493	0.000995	CbGpPWpGaD
Carvedilol—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000489	0.000986	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000489	0.000986	CbGpPWpGaD
Carvedilol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000483	0.000974	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00048	0.000968	CbGpPWpGaD
Carvedilol—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000466	0.00094	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000466	0.00094	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000464	0.000936	CbGpPWpGaD
Carvedilol—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000457	0.000921	CbGpPWpGaD
Carvedilol—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000449	0.000907	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000446	0.0009	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000444	0.000895	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000434	0.000876	CbGpPWpGaD
Carvedilol—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000433	0.000874	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000433	0.000873	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.000428	0.000863	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000412	0.000832	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000403	0.000814	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000399	0.000805	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000393	0.000792	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000376	0.000758	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000372	0.000751	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000371	0.000748	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00037	0.000747	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000368	0.000742	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000368	0.000742	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000358	0.000722	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000357	0.000721	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000348	0.000702	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000342	0.000691	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000335	0.000676	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000334	0.000674	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000333	0.000671	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000332	0.00067	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000328	0.000662	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000325	0.000657	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000325	0.000655	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000324	0.000654	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000322	0.000651	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000318	0.000642	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00031	0.000626	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000305	0.000616	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000304	0.000614	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000304	0.000613	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000303	0.000612	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000303	0.000611	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000302	0.00061	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000302	0.00061	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000302	0.000609	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000301	0.000608	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.0003	0.000606	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000298	0.000601	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000297	0.000598	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000296	0.000598	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000296	0.000597	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000296	0.000596	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000294	0.000593	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000293	0.000592	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000293	0.000591	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000289	0.000583	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000282	0.00057	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000282	0.000568	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000281	0.000566	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000279	0.000562	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000277	0.000559	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	0.000276	0.000557	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000276	0.000557	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000275	0.000555	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000274	0.000553	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000274	0.000552	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000273	0.000552	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000273	0.00055	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000271	0.000547	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000269	0.000543	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000269	0.000543	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000263	0.000531	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000255	0.000514	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000252	0.000508	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000251	0.000506	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000246	0.000497	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000245	0.000495	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000245	0.000494	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000239	0.000482	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000236	0.000476	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000233	0.00047	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000229	0.000462	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000228	0.00046	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000223	0.000449	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000222	0.000448	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00022	0.000443	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000212	0.000428	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000212	0.000427	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00021	0.000424	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000208	0.000419	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000207	0.000418	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000197	0.000398	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000197	0.000397	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000193	0.00039	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000193	0.000389	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000192	0.000387	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000192	0.000387	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000191	0.000386	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000191	0.000385	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000189	0.000381	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000182	0.000368	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00018	0.000363	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000178	0.00036	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000178	0.00036	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000178	0.00036	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000176	0.000355	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000176	0.000354	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000175	0.000352	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000173	0.000349	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000172	0.000347	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000171	0.000345	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000166	0.000336	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000164	0.000331	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000163	0.000328	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000162	0.000326	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000161	0.000325	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00016	0.000322	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000159	0.000321	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000159	0.000321	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000156	0.000315	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000151	0.000304	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000148	0.000299	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000145	0.000294	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000145	0.000292	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000141	0.000285	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000135	0.000273	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000132	0.000265	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000131	0.000265	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000125	0.000252	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000122	0.000247	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000114	0.00023	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000113	0.000228	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000111	0.000225	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000105	0.000213	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000104	0.000209	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.22e-05	0.000186	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.56e-05	0.000173	CbGpPWpGaD
